NeuronNeurosciencePeer-reviewed journal article
Integrated stress response associated with dark microglia promotes microglial lipogenesis and contributes to neurodegeneration
Anna G. FluryiD, Leen AljayousiiD, Hye-Jin ParkiD, Mohammadparsa KhakpouriD, Jack Mechler, Siaresh Aziz, Jackson D. McGrath, Pragney DemeiD, Colby Sandberg, Fernando Gonzàlez IbáñeziD, Olivia Braniff, Thi Ngo, Simira SmithiD, Matthew Velez, Denice Moran Ramirez, Dvir Avnon-KleiniD, John W. MurrayiD, Jia LiuiD, Martin ParentiD, Susana MingoteiD, Norman J. HaugheyiD, Sebastian WerneburgiD, Marie‐Ève TremblayiD, Pinar AyataiD
- Citations
- 96
- FWCI
- 14.73
- Field percentile
- top 1%
Abstract
Microglia, the brains primary resident immune cells, are a heterogeneous population and can assume phenotypes with diverse functional outcomes on brain homeostasis. In Alzheimers disease (AD), where microglia are a leading causal cell type, microglia subsets with protective functions have been well characterized. Yet, the identity of microglia subsets that drive neurodegeneration remains unresolved. Here, we identify a neurodegenerative microglia phenotype that is characterized by a conserved stress signaling pathway, the integrated stress response (ISR). Using mouse models to activate or inhibit ISR in microglia, we show that ISR underlies the ultrastructurally distinct "dark" microglia subset linked to pathological synapse loss. Inducing microglial ISR in murine AD models exacerbates neurodegenerative pathologies, such as Tau pathology and synaptic terminal loss. Conversely, inhibiting microglial ISR in AD models ameliorates these pathologies. Mechanistically, we present evidence that ISR promotes the secretion of toxic long-chain lipids that impair neuron and oligodendrocyte homeostasis in vitro. Accordingly, small molecule-based inhibition of lipid synthesis in AD models ameliorates synaptic terminal loss. Our results demonstrate that activation of ISR within microglia represents a novel pathway contributing to neurodegeneration and suggest that this may be sustained, at least in part, by the secretion of long-chain lipids from ISR-activated microglia.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of Insulin Signaling in Microglia Impairs Cellular Uptake of Aβ and Neuroinflammatory Response Exacerbating Alzheimer-like Neuropathology
Wenqiang Chen, Xiangyu Liu, … C. Ronald Kahn·bioRxiv·Aug 22, 2024
- Inhibition of IL34 unveils tissue-selectivity and is sufficient to reduce microglial proliferation in chronic neurodegeneration
Juliane Obst, Emilie Simon, … Diego Gómez‐Nicola·Frontiers in ImmunologyPeer-reviewed·Oct 8, 2020
- Non-mutated human tau stimulates Alzheimer's disease-relevant neurodegeneration in a microglia-dependent manner
Ethan R. Roy, Qiang Wang, … Wei Cao·Scientific ReportsPeer-reviewed·Jul 29, 2025
- Dynamic neuroinflammatory profiles predict Alzheimer's disease pathology in microglia-containing cerebral organoids
Madison K. Kuhn, Rachel Y. Kang, … Elizabeth A. Proctor·bioRxiv·Nov 16, 2023
- Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors
Linh Le, Alexis M. Feidler, … Ania Katarzyna Majewska·bioRxiv·Dec 1, 2023
- Lipid Accumulation Induced by APOE4 Impairs Microglial Surveillance of Neuronal-Network Activity
Matheus B. Victor, Noelle Leary, … Li‐Huei Tsai·Cell stem cellPeer-reviewed·Aug 1, 2022